Drug intelligence / Profile preview

MENISC-T

Development stage: Unknown
Modality: Implantable Devices → Device-based Delivery → Drug Delivery Systems
Administration: Surgical Implantation

Overview

MENISC-T is a treated, devitalized, and sterile meniscus segment intended for use as an implant in the treatment of scaphotrapeziotrapezoid osteoarthritis. It is a biological product derived from donor meniscal tissue that has been processed to remove cellular components (devitalized) and sterilized to ensure safety. The primary mechanism involves providing structural support and cushioning within the joint, potentially replacing or augmenting damaged native meniscal tissue. This approach aims to restore joint function and reduce pain associated with osteoarthritis in the targeted wrist region[8].

Brand names: MENISC-T
Other names: MENISC-T

Beyond the preview

Go deeper on MENISC-T.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MENISC-T.

Explore the full profile